Prognostic factors and long-term survivorship in patients with recurrent or metastatic head and neck cancer (HNC): An analysis of two Eastern Cooperative Oncology Group (ECOG) randomized trials

A. Argiris,Yi Li,A. Forastière

Prognostic factors and long-term survivorship in patients with recurrent or metastatic head and neck cancer (HNC): An analysis of two Eastern Cooperative Oncology Group (ECOG) randomized trials

2004

A. Argiris
Yi Li
A. Forastière

5514 Background: The ECOG conducted two successive phase III randomized trials comparing cisplatin-based doublets (E1393: cisplatin/paclitaxel, low dose vs. cisplatin/paclitaxel, high dose, and E13...

Keywords:

Randomized controlled trial
Pathology
Oncology
Long Term Survivorship
Head and neck cancer
Medicine
Internal medicine
Paclitaxel
low dose
in patient
Cisplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations